Clinical Research Directory
Browse clinical research sites, groups, and studies.
Management of Epistaxis Comparing Nasal Packing Versus Greater Palatine Foramen Block
Sponsor: Sheikh Zayed Federal Postgraduate Medical Institute
Summary
The goal of this pilot randomized controlled trial is to compare pain relief efficacy while using nasal packing versus greater palatine foramen block (GPFB) in the management of acute episodes of epistaxis. The main questions it aims to answer are: Does GPFB have less potential to inflict pain when dealing with hemostasis with epistaxis, utilizing a pre-validated 10-point visual analog scale (VAS)? Was hemostasis management more effective in either technique? Researchers will compare anterior nasal packing to greater palatine foramen block using 2% xylocaine with adrenaline. Patients will receive any of the hemostatic interventions at the time of the acute epistaxis episode. The questionnaire will be administered 24 hours post-intervention.
Official title: A Pilot Randomized Controlled Trial in Management of Epistaxis Comparing Nasal Packing Versus Greater Palatine Foramen Block
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-03-01
Completion Date
2027-02-28
Last Updated
2026-02-24
Healthy Volunteers
No
Interventions
Greater Palatine Foramen Block with 2% xylocaine with adrenaline
Patients allocated to this group will receive a greater palatine foramen block using a local anaesthetic agent (2% i.e. 20mg/dL Inj. Lidocaine with adrenaline) administered at the greater palatine foramen under aseptic conditions. Patients will be monitored for local anaesthetic as well as GPF block-related adverse effects. Hemostasis will be assessed following the procedure.
Anterior Nasal Packing
Patients allocated to this group will receive anterior nasal packing using standard non-absorbable nasal packs following institutional protocol. Packs will remain in situ for 24-72 hours, unless earlier removal is clinically indicated.